Healthcare-focused investment firm with $5.3B in AUM, investing in public and private life sciences companies globally. Investments have led to 52 marketed products across oncology, immunology, and rare diseases.
€5M – €50M
Fund size: $5.3B regulatory AUM; $740M Opportunity Fund III; 430+ companies invested globally
Browse similar check sizes →Create your pitch deck with AI, get investor-ready feedback, and find the right investors for your startup.
Get started free